-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
16 Dec 2025 03:09 GMT
… HER2-positive metastatic breast cancer
Breast cancer is the second … day eliminate breast cancer as a cause of death. … new breast cancer settings.
In HR-positive breast cancer, AstraZeneca … negative breast cancer, an aggressive form of breast cancer, AstraZeneca …
-
Breast cancer disrupts stress hormone rhythms in the brain
16 Dec 2025 02:28 GMT
… lab has found that breast cancer disrupts the diurnal, or … throughout the day. In breast cancer, the team found that … find that in mice, breast cancer can disrupt those rhythms … -cancer immune cells into breast tumors, causing them to shrink significantly. …
-
Medical Software Company Agrees to Pay $500,000 to Resolve Allegations of Causing Medically Unnecessary Breast Cancer Screening Claims
16 Dec 2025 01:03 GMT
… False Claims Act by causing health care providers to … MassHealth for medically unnecessary breast cancer screenings.
PenRad’s software … from something other than breast cancer. The Tyrer-Cusick … elevated risk scores, which caused those patients to receive …
-
<![CDATA[FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer]]>
15 Dec 2025 23:56 GMT
… patients with HER2-positive breast cancer for treatment with Enhertu … HER2-positive advanced or metastatic breast cancer. Eligible patients had either … enters these cells and causes DNA damage, leading to … binds to HER2 and causes cancer cells to stop growing …
-
<![CDATA[FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer]]>
15 Dec 2025 21:47 GMT
… inhibit growth, which causes the antibody to be … with HER2 positive metastatic breast cancer,” DESTINY-Breast09 trial … with HER2 Positive Metastatic Breast Cancer. News release. AstraZeneca. … -patients-her2-positive-breast-cancer-who-have-progressed-available …
-
<![CDATA[Sentinel Lymph Node Biopsy Omission Shows Feasibility in Select HR+ Breast Cancer]]>
15 Dec 2025 21:33 GMT
… breast cancer (37%), second non-breast cancer (46%), other known cause … recurrence, contralateral breast cancer, and distant metastasis … non-breast cancer, other known cause, and unknown cause occurred … with early-stage breast cancer. American Association …
-
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
15 Dec 2025 20:06 GMT
… Positive Metastatic Breast Cancer
Breast cancer is the second … causes of cancer-related deaths worldwide.1 More than two million breast cancer … breast cancer.4 HER2 positive metastatic breast cancer … HER2-Positive Metastatic Breast Cancer
– In combination …
-
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
15 Dec 2025 17:02 GMT
… .
Anixa's breast cancer vaccine, developed in collaboration … Distinguished Chair in Innovative Breast Cancer Research at Cleveland Clinic. … our control, which may cause our actual results, … transfer-of-ind-for-breast-cancer-vaccine-from-cleveland- …
-
Breakthrough in breast cancer care: New vaccine targets triple-negative cases, result brings hope
15 Dec 2025 10:25 GMT
… vaccine targeting triple-negative breast cancer (TNBC), one … inside.
Breakthrough in breast cancer care: New vaccine targets … breast cancers, yet it causes a disproportionate number of breast cancer- … in how aggressive breast cancers are prevented and …
-
Cure Bowl cause hits close to home for Rahne, Monarchs
16 Dec 2025 01:20 GMT
… . "My mom is a breast cancer survivor and so it was … seats come kickoff, supporting a cause their family knows all too … .
"Her mom died from breast cancer," he said. "It …
About
© 1995-2025